Champions Oncology UK Ltd

Champions Oncology UK Ltd. is a wholly owned subsidiary of Champions Oncology, Inc., a public revenue-generating oncology drug development company with an innovative platform technology called Champions TumorGrafts™, preclinical models of cancer that preserve the original characteristics of the human tumour.  The company offers its predictive platform and tumour specific database to physicians to enhance personalised patient care and to BioPharma companies for evaluation of oncology drugs in a platform which integrates predictive testing with biomarker discovery.